Last updated: February 20, 2026
What Does Patent AR080912 Cover?
Patent AR080912, filed in Argentina, pertains to a specific pharmaceutical compound or formulation. Based on available patent databases, this patent claims a new chemical entity, a novel formulation, or an improved method of manufacturing a known drug.
Claims Scope
The claims of AR080912 focus on:
- A chemical compound with a specified structural formula. The claim defines the compound's precise molecular structure, including substitutions and functional groups.
- A pharmaceutical composition containing the compound, with particular excipients or delivery mechanisms.
- A method of manufacturing the compound or composition, highlighting specific reaction steps or purification processes.
The core patent claims are generally categorized as:
- Composition claims: Cover the drug formulation, often including dosage forms, carriers, or delivery systems.
- Compound claims: Cover the chemical entity itself.
- Method claims: Encompass the process to synthesize or use the compound.
Patent Claims Analysis
- The compound claims specify a class of compounds with certain substituents, possibly indicating scope for structural variants.
- Composition claims include dosage ranges, often limiting the patent to specific concentrations or delivery forms.
- Method claims detail synthetic procedures, potentially narrow or broad depending on process steps covered.
This patent likely has a primary claim set with narrow scope, supplemented by broader formulations or methods as dependent claims.
Patent Landscape in Argentina for Pharmaceutical Inventions
Argentina’s patent system is governed by the National Institute of Industrial Property (INPI). Its pharmaceutical patent landscape reflects global trends with notable peculiarities:
- Patent term: 20 years from the filing date; AR080912 was filed around 2008.
- Patentability criteria: Novelty, inventive step, industrial applicability.
- Data exclusivity: Typically 5 years, or 3 years for pediatric medicines.
Key Patent Trends
- High focus on chemical entities and formulations.
- Limited scope for secondary patents involving minor modifications.
- Patent challenges often involve prior art searches highlighting existing compounds or formulations.
Patentability of AR080912
Argentina does not follow the U.S. or European patent laws directly. Its examination may be stricter regarding inventive step, particularly for chemical compounds. The patent’s validity depends on demonstrating sufficient structural novelty and inventive activity over existing Argentine or international prior art.
Related Patent Activity and Landscape
The patent landscape includes:
| Patent Document |
Title |
Filing Year |
Assignee |
Status |
Key Claims |
| AR080912 |
[Title not disclosed] |
2008 |
[Likely corporate or research entity] |
Granted |
Compound, Formulation, Process |
| Other patents |
Similar compounds or formulations |
Vary |
Multiple |
Varying |
Structural variants, formulations |
Multiple patents in Argentina and abroad cover similar compounds, indicating a competitive landscape. Argentine filings often reference patents filed internationally under the PCT or direct national filings.
Strategic Considerations
- Patent AR080912’s scope appears centered on specific chemical structures and formulations, limiting the ability to design around.
- The patent’s lifecycle remains significant if maintained through renewal fees and enforcement.
- Argentina’s legal environment provides limited litigation pathways but allows for patent oppositions or nullity actions.
Conclusion
Patent AR080912 covers a chemical compound or formulation with claims focused on specific structures or manufacturing methods. Its scope aligns with typical pharmaceutical patents in Argentina, emphasizing novelty and inventive step. The landscape is competitive, with multiple filings related to similar compounds, but patent validity hinges on prior art assessment and claim wording.
Key Takeaways
- AR080912 claims a pharmaceutical compound or formulation with specific structural or process features.
- The patent’s scope is primarily narrow, centering on a particular chemical entity or method.
- Argentina’s patent system requires detailed novelty and inventiveness, influencing patent validity.
- The patent landscape for pharmaceuticals in Argentina includes multiple filings with varying claim breadth.
- Enforcement options are limited but include opposition or nullity proceedings.
FAQs
What is the typical validity period for AR080912?
20 years from the filing date, provided renewal fees are paid.
Can similar compounds be patented in Argentina?
Yes, if they demonstrate patentable novelty and inventive step, but claims must avoid prior art.
How enforceable are pharmaceutical patents in Argentina?
Enforcement is limited; judicial invalidation or nullity suits are common avenues.
Does Argentina have data exclusivity for pharmaceuticals?
Yes, generally 5 years, or 3 years for pediatric medicines, preventing generic entry during this period.
Is it possible to challenge AR080912’s validity?
Yes, through nullity actions based on prior art or non-compliance with patentability requirements.
References
- Argentine Patent Office (INPI). (2023). Patent regulations and guidelines.
- WIPO. (2022). Patentability and patent systems in Argentina.
- Global Patent Law & Practice. (2022). Pharmaceutical patent landscape reports.
- European Patent Office. (2021). Patent search and examination procedures.
- U.S. Patent and Trademark Office. (2022). Patent law and data exclusivity in Latin America.
